Pell Bio-Med Technology Co., Ltd. operates as a biotechnology company. It provides cell culture technology development, clinical application of cell therapy and other services. The company was founded on March 30, 2017 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company